Thiazolidinediones: Single-dose pharmacokinetics of rosiglitazone was not meaningfully altered in subjects receiving multiple daily doses of sitagliptin, indicating that sitagliptin is not an inhibitor of CYP2C8-mediated metabolism
Medication handles the metabolic component
The most common side effects of GLP-1 receptor agonists include nausea, vomiting, constipation, and diarrhea
Steady weight change : One to two pounds per week, or measurable changes in waist circumference
This medication is 94% similar to the natural GLP-1 hormone and, just like the natural version, it binds to GLP-1 receptors in your pancreas and other organs
The drug was used in a double-blind, randomised, placebo-controlled trial including 526 adult participants with type 2 diabetes across China, India, Japan, Mexico, and the United States